Copmressed

Pioneering a Path Forward

At Rhythm Pharmaceuticals, we’re committed to advancing scientific understanding to improve the lives of people living with rare melanocortin-4 receptor (MC4R) pathway diseases

Rhythm is a biopharmaceutical company dedicated to transforming the lives of patients and their families living with hyperphagia (insatiable hunger) and severe obesity caused by rare MC4R pathway diseases.1


Our expertise and close collaboration with patients, caregivers, and healthcare professionals enable us to understand the complex challenges of rare MC4R pathway diseases and identify where the most significant unmet needs lie.

We combine translational research and clinical development to deliver integrated precision medicine that tackles the toughest challenges in rare MC4R pathway diseases today and into the future.

molecules-v2DNA-HD

Find out about what
we do at Rhythm

Join us at Rhythm

References

Hide

da Fonseca ACP, et al., J Diabetes Complications. 2017;31(10):1549-1561